FakoredeF: Increasing awareness this national diabetes month can save limbs and lives. AJMC Web site. Available at: https://www.ajmc.com/view/increasing-awareness-this-national-diabetes-month-can-save-limbs-and-lives. Published November 29, 2018.)| false
ThorudJ, PlemmonsB, BuckleyC, et al: Mortality after nontraumatic major amputation among patients with diabetes and peripheral vascular disease: a systematic review. J Foot Ankle Surg55: 591, 2016.10.1053/j.jfas.2016.01.01226898398)| false
JupiterD, ThroudJ, BuckleyC, et al: The impact of foot ulceration and amputation on mortality in diabetic patients: I. From ulceration to death, a systematic review. Int Wound J13: 892, 2016.2560135810.1111/iwj.12404)| false
O'BrienP, CoxM, ShortellC, et al: Risk factors for early failure of surgical amputations: an analysis of 8,878 isolated lower extremity amputation procedures. J Am Coll Surg216: 836, 2013.10.1016/j.jamcollsurg.2012.12.04123521969)| false
MacEwanM, MacEwanS, KovacsT, et al: What makes the optimal wound healing material? a review of current science and introduction of a synthetic nanofabricated wound care scaffold. Cureus9: e1736, 2017.29209583)| false
MacEwanMR, MacEwanS, WrightAP, et al: Comparison of a fully synthetic electrospun matrix to a bi-layered xenograft in healing full thickness cutaneous wounds in a porcine model. Cureus9: e1614, 2017.
MacEwanMR, MacEwanS, WrightAP, et al: Comparison of a fully synthetic electrospun matrix to a bi-layered xenograft in healing full thickness cutaneous wounds in a porcine model. Cureus9: e1614, 2017.)| false
Background: Transmetatarsal amputation (TMA) is a viable option to avoid major amputation and limb loss in patients with forefoot sepsis, infection, or tissue loss. However, TMAs are associated with a significant incidence of dehiscence, readmission, and reoperation rates ranging from 26% to 63%. To encourage tissue healing, neovascularization, and durable closure, a nonwoven, resorbable, synthetic hybrid-scale fiber matrix whose architecture is similar to native human extracellular matrix was used in an augmented closure technique. We comparatively evaluated clinical outcomes and complication rates in TMA procedures with and without augmented closure.
Methods: A retrospective analysis of ten patients who underwent TMA with augmented closure using the synthetic matrix and ten patients who underwent TMA with standard primary closure was conducted.
Results: After TMA, 80% of the patients who underwent augmented closure demonstrated complete wound healing compared with 60% of the control group. Patients undergoing augmented closure demonstrated five instances of wound dehiscence and 20% limb loss compared with eight instances of wound dehiscence and 40% limb loss in the control group. After TMA and augmented closure, patients required eight interventional procedures before complete healing compared with patients undergoing standard closure, who required 13 interventional procedures before complete healing.
Conclusions: Augmented closure of surgical wounds after TMA using a synthetic hybrid-scale fiber matrix provided a unique means of reducing time to healing (18%), wound dehiscence (29%), number of procedures performed (39%), and rate of limb loss (20%). Augmented closure, therefore, offers a means of improving quality of life and reducing risk for patients undergoing TMA, and potentially reducing total cost of care.
Corresponding author: Jeffery Alexander, DPM, Podiatry Section, Department of Orthopedic Surgery, Rush University Medical Center, 610 S Maple Ave, #2550, Oak Park, IL 60304. (E-mail: email@example.com)